NANOTECHNOLOGYMETAST
TREATING METASTATIC CANCER WITH NANOTECHNOLOGY
| Coordinatore | TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Organization address
address: TECHNION CITY - SENATE BUILDING contact info |
| Nazionalità Coordinatore | Israel [IL] |
| Totale costo | 100˙000 € |
| EC contributo | 100˙000 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2012-CIG |
| Funding Scheme | MC-CIG |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-04-01 - 2017-03-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY
Organization address
address: TECHNION CITY - SENATE BUILDING contact info |
IL (HAIFA) | coordinator | 100˙000.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Metastasis – the spread of cancer to distant organs, poses a great therapeutic challenge. Nanomaterials have many therapeutic advantages, such as the ability to target specific tissues and carry multiple drugs, making them promising candidates for treating metastasis. Despite the great need, there is a gap in the fundamental understanding what structural parameters can enhance the targeting capacity of nanomaterials to metastatic sites. This program is aimed at elucidating the mechanism by which therapeutic nanomaterials can be designed to target and treat metastatic cancer.'